{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:20:42Z","timestamp":1792153242300,"version":"4.4.0"},"reference-count":18,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The neuro-ophthalmological manifestations of Behcet\u2019s disease (BD) are rare, and data regarding their characteristics and outcome are lacking.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To report prevalence, main characteristics and outcome of neuro-ophthalmological manifestations in BD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and methods<\/jats:title><jats:p>This is a retrospective monocentric study of 217 patients diagnosed with neuro-Beh\u00e7et\u2019s disease (NBD), of whom 29 (13.3%) patients presented with neuro-ophthalmological manifestations (55% of men and mean\u00b1SD age of 26\u00b18 years). All patients underwent a detailed ophthalmological examination and were followed up in the internal medicine and the ophthalmology departments.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Neuro-ophthalmological manifestations were the first presentation of BD in 45% of patients and developed later in the course of the disease in 55% of patients. They are divided into parenchymal (PM) and non-parenchymal (NPM)-related manifestations in, respectively, 13 patients (45%) and 16 patients (55%). PM included papillitis in seven patients (53.8%), retrobulbar optic neuritis in four patients (30.8%) and third cranial nerve palsy in two patients (15.4%). NPM included papilloedema related to cerebral venous thrombosis in all 16 patients, of whom 6 patients (37.5%) had sixth cranial nerve palsy. At initial examination, 93.1% of patients had visual alterations, including mainly decreased visual acuity visual field defects and\/or diplopia. All patients were treated with corticosteroids and 79% of patients received immunosuppressive agents. After treatment, the visual outcome improved or stabilised in 66.7% of patients while it worsened in 33.3. The mean\u00b1SD logarithm of the minimum angle of resolution visual acuity improved from 0.4\u00b10.3 at diagnosis to 0.2\u00b10.3 after therapy. 10.3% and 3.4% of patients were legally blind at diagnosis and after therapy, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Neuro-ophthalmological manifestations of BD\u00a0represented 13% of NBD. They could be potentially severe and disabling. Prompt treatment is the key factor in improving visual outcome.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bjophthalmol-2017-311334","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T16:25:34Z","timestamp":1524759934000},"page":"83-87","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":23,"title":["Neuro-ophthalmological manifestations of Beh\u00e7et\u2019s disease"],"prefix":"10.1136","volume":"103","author":[{"given":"Ammr","family":"Alghamdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahram","family":"Bodaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Comarmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Claire","family":"Desbois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Domont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Wechsler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Depaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuc","family":"Le Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Cacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Touitou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Saadoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,4,26]]},"reference":[{"key":"2020050713021255000_103.1.83.1","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/1346-8138.13381","article-title":"Beh\u00e7et\u2019s disease: a comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions","volume":"43","author":"Alpsoy","year":"2016","journal-title":"J Dermatol"},{"key":"2020050713021255000_103.1.83.2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.revmed.2013.10.332","article-title":"[Neurological manifestations of Beh\u00e7et\u2019s disease]","volume":"35","author":"Noel","year":"2014","journal-title":"Rev Med Interne"},{"key":"2020050713021255000_103.1.83.3","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-010-5454-2"},{"key":"2020050713021255000_103.1.83.4","doi-asserted-by":"publisher","DOI":"10.1002\/art.24393"},{"key":"2020050713021255000_103.1.83.5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/BF00596576","article-title":"A controlled study of reliability and validity of MRI findings in neuro-Beh\u00e7et\u2019s disease","volume":"38","author":"Coban","year":"1996","journal-title":"Neuroradiology"},{"key":"2020050713021255000_103.1.83.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2007.01754.x"},{"key":"2020050713021255000_103.1.83.7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker449"},{"key":"2020050713021255000_103.1.83.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70015-8"},{"key":"2020050713021255000_103.1.83.9","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.74.5.608"},{"key":"2020050713021255000_103.1.83.10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/RHU.0b013e31827d8c5d","article-title":"Papilledema caused by cerebral venous sinus thrombosis in a patient with Beh\u00e7et disease","volume":"19","author":"Aydin","year":"2013","journal-title":"J Clin Rheumatol"},{"key":"2020050713021255000_103.1.83.11","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.revmed.2008.12.021","article-title":"[Optic neuropathy in Beh\u00e7et\u2019s disease: a series of 18 patients]","volume":"30","author":"Frigui","year":"2009","journal-title":"Rev Med Interne"},{"key":"2020050713021255000_103.1.83.12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0021-5155(01)00466-X","article-title":"Optic nerve involvement in neuro-Behcet's disease","volume":"46","author":"Nakamura","year":"2002","journal-title":"Jpn J Ophthalmol"},{"key":"2020050713021255000_103.1.83.13","first-page":"9","article-title":"Involvement of the optic nerve in the course of Behcet\u2019s disease (presentation of 148 cases)]","volume":"289","author":"Lamari","year":"2003","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"2020050713021255000_103.1.83.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01613.x"},{"key":"2020050713021255000_103.1.83.15","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/122.11.2171"},{"key":"2020050713021255000_103.1.83.16","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.revmed.2005.06.015","article-title":"[Ocular manifestation of Beh\u00e7et disease (study of 50 patients consulting in dermatology department)]","volume":"26","author":"Janati","year":"2005","journal-title":"Rev Med Interne"},{"key":"2020050713021255000_103.1.83.17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3349\/ymj.1999.40.3.294","article-title":"Neuro-Behcet\u2019s disease presenting with isolated unilateral lateral rectus muscle palsy","volume":"40","author":"Lew","year":"1999","journal-title":"Yonsei Med J"},{"key":"2020050713021255000_103.1.83.18","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0035-3787(06)75121-9","article-title":"[Neurological involvement in Beh\u00e7et\u2019s disease. 154 cases from a cohort of 925 patients and review of the literature]","volume":"162","author":"Benamour","year":"2006","journal-title":"Rev Neurol"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2017-311334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:56:29Z","timestamp":1601110589000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2017-311334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,26]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12,13]]},"published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.1136\/bjophthalmol-2017-311334"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311334","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,26]]}}}